Drug Information Association's 3rd Annual Conference On Drug Discovery And Clinical Development In India

Main Category: Conferences
Also Included In: Pharma Industry / Biotech Industry
Article Date: 15 Oct 2008 - 3:00 PDT

email to a friend   printer friendly   opinions  

The Drug Information Association (DIA) will host the 3rd Annual Conference on Drug Discovery and Clinical Development in India (December 7-10; Mumbai, India) will continue its tradition of addressing current solid scientific research in India pertaining to global development of drugs and biologics.

Driven by the need to improve R&D productivity and efficiency and the desire to access untapped markets, global pharmaceutical companies have increasingly off shored and outsourced operations to India. A wide array of factors, however, can dictate whether such a move is successful. DIA will convene global experts from industry, academia, and regulatory for a provocative discussion on the challenges and issues facing drug discovery and clinical development in India. Topics will include:

• Development of Medical Devices: Global Regulatory Requirements
• Opportunities for Establishing Globally Centralized Laboratories in India
• India's Patent Laws and their impact on Biopharmaceutical Industry
• India vs. ICH Regulatory Framework for Safety Reporting
• Bioinformatics and Biometrics
• Clinical Trials
• Combination Products
• Drug Delivery
• Drug Discovery
• Development of Anticancer Drugs and Biologics: PK
• Development of Biologics
• Pharmacology and Toxicology
• Pharmacovigilance
• Quality by Design
• Vaccine - The Challenge for Regulatory and Innovators
• Ethics in Clinical Research

Rashmi Barbhaiya, Ph.D, CEO, Managing Director and Co-founder of Advinus Therapeutics, and Surinder Singh, MD, Drug Controller General of India, will deliver the keynote addresses.

About the Drug Information Association (DIA)

DIA serves more than 30,000 professionals in the biotechnology, pharmaceutical and regulatory industries worldwide. Through its domestic and international meetings, training courses, workshops and webinars, DIA provides a neutral global forum for the exchange of information critical to the advancement of the drug discovery and lifecycle management processes. Headquartered in Horsham, PA, USA, and with offices in Basel, Switzerland, Tokyo, Japan, and Mumbai, India, the Association is led by its volunteer-based Board of Directors and executive management team. For more information, visit http://www.diahome.org or call 215-442-6100.

Source:
Joe Krasowski
Drug Information Association

• Additional
• References
• Citations